CRT+ARC技术在局部晚期肺癌患者中临床应用的初步研究

doi:10.11904/j.issn.1002-3070.2019.03.012

实用肿瘤学杂志 ›› 2019, Vol. 33 ›› Issue (3): 256-260.doi: 10.11904/j.issn.1002-3070.2019.03.012

CRT+ARC技术在局部晚期肺癌患者中临床应用的初步研究

张彦秋¹,韩阿蒙²,李金旺¹,顾涛¹,付占昭¹,毛羽¹,张子健³,杨振³

1.秦皇岛市第一医院放疗科(秦皇岛 066000);
2.燕山大学信息中心;
3.中南大学湘雅医院肿瘤科

收稿日期:2018-11-02 修回日期:2019-02-27 出版日期:2019-06-20 发布日期:2019-06-18
通讯作者: 顾涛,E-mail:gt529@126.com
作者简介:张彦秋,女,(1983-),硕士,主管技师,从事肿瘤放射治疗物理学方面的研究
基金资助:
2016年河北省科技计划项目(编号:162777171)

The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer

ZHANG Yanqiu¹,HAN Ameng²,LI Jinwang¹,GU Tao¹,FU Zhanzhao¹,MAO Yu¹,ZHANG Zijian,YANG Zhen³

1.Department of Radiation Therapy,The First Hospital of Qinhuangdao,Qinhuangdao 066000,China;
2.Center of Information Technology,Yanshan University;
3.Department of Radiation Oncology,Central South University of Xiangya Hospital

Received:2018-11-02 Revised:2019-02-27 Online:2019-06-20 Published:2019-06-18

摘要/Abstract

摘要： 目的研究CRT+ARC技术在局部晚期肺癌中临床应用情况。方法选择2016年3月1日—2017年3月1日在我院放疗科放疗的100例局部晚期肺癌患者,随机分为实验组和对照组,每组各50例患者,实验组制定CRT+ARC计划,对照组制定三维适形放射治疗技术+调强放射治疗技术(Intensity-modulated radiotherapy,IMRT)(CRT+IMRT)计划。根据世界卫生组织(World health organization,WHO)标准评估患者的近期疗效,根据影像学检查及放射治疗肿瘤学组(Radiaton therapy ognization group,RTOG)标准明确放疗主要副反应放射性肺炎发生情况。结果实验组治疗有效率为82%,对照组治疗有效率为76%,两组差异无统计学意义(χ²=0.542,P=0.461)。实验组肺炎发生率为22%,对照组肺炎发生率18%,两组差异无统计学意义(χ²=0.250,P=0.617)。结论 CRT+ARC技术在局部晚期肺癌临床应用中,与CRT+IMRT相比,近期疗效和主要的副反应放射性肺炎都没有统计学差异。

关键词: CRT+ARC, 肺癌, 临床应用, 放射性肺炎

Abstract: Objective This paper investigated the clinical application of CRT+ARC technique in locally advanced lung cancer.Methods A total of 100 patients with locally advanced lung cancer who underwent radiotherapy in our hospital from March 1,2016 to March 1,2017 were randomly assigned to the experimental and control groups.Each group consisted of 50 patients.The CRT+ARC plans were made for the experimental group,and the CRT + intensity-modulated radiotherapy(IMRT)(CRT+IMRT)plans for the control group.According to the World Health Organization(WHO)criteria,the short-term efficacy of patients was assessed.According to the imaging examination and the Radiation Therapy Organization Group(RTOG)standard,the occurrence of major side effects of radiation pneumonia was identified.Results The effective rate of treatment was 82% in the experimental group and 76% in the control group.There was no difference in the effective rate between the two groups(χ²=0.542,P=0.461).The incidence of pneumonia in the experimental group was 22%,and 18% in the control group.There was also no difference in the incidence of pneumonia between the two groups(χ²=0.250,P=0.617).Conclusion In the clinical application of locally advanced lung cancer,CRT+ARC technique has no difference in the short-term efficacy and the main side effects of radiation pneumonitis compared with CRT+IMRT.

Key words: CRT+ARC technique, Lung cancer, Clinical application, Radionuclide pneumonia

中图分类号:

R811.1

张彦秋,韩阿蒙,李金旺,顾涛,付占昭,毛羽,张子健,杨振. CRT+ARC技术在局部晚期肺癌患者中临床应用的初步研究[J]. 实用肿瘤学杂志, 2019, 33(3): 256-260.

ZHANG Yanqiu,HAN Ameng,LI Jinwang,GU Tao,FU Zhanzhao,MAO Yu,ZHANG Zijian,YANG Zhen. The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 256-260.

参考文献 1

孙明亮,徐建宇,徐向英.早期非小细胞肺癌立体定向放疗的相关研究[J].实用肿瘤学杂志,2018,32(1):53-56.2 杜夜生,胡松柳,徐向英.非小细胞肺癌寡转移的立体定向放射治疗研究[J].实用肿瘤学杂志,2018,32(2):154-158.3 Sapkaroski D,Osborne C,Knight KA,et al.A review of stereotactic body radiotherapy-is volumetric modulated arc therapy the answer?[J].J Med Radiat Sci,2015,62(2):142-151.4 Fitzgerald R,Owen R,Hargrave C,et al.A comparison of three different VMAT techniques for the delivery of lung stereotactic ablative radiation therapy[J].J Med Radiat Sci,2016,63(1):23-30.5 Yamgguchi S,Ohguri T,Matsuki Y,et al.Radiothrapy for thoracic tumors:association between subclinical interstitial lung disease and fatal radiation pneumonitis[J].Int J Clin Oncol,2015,20(1):45-52.6 Kannarunimit D,Descovich M,Garcia A,et al.Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors:a comparison of robotic radiosurgery,helical tomotherapy and volumetric modulated arc therapy[J].Technol Cancer Res Treat,2015,14(1):49-60.7 Ferrero C,Badellino S,Filippi AR,et al.Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC:a prospective study[J].Lung Cancer,2015,89(3):350-356.8 张彦秋,韩阿蒙,李金旺,等.CRT+ARC技术在肺癌"T"形靶区患者放射治疗中的剂量学研究[J].中国医学物理学杂志,2017,34(7):712-718.9 Zhao Y,Chen L,Zhang S,et al.Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer[J].Thorac Cancer,2015,6(1):49-57.10 Yokouchi H,Miyazaki M,Miyamoto T,et al.Post-recurrence survival after surgical resection of non-small cell lung cancer with local recurrence[J].Gan To Kagaku Ryoho,2014,41(12):2050-2052.11 Wijsman R,Dankers FJWM,Troost EGC,et al.Inclusion of incidental radiation dose to the cardiac atria and ventricles does not improve the prediction of radiation pneumonitis in advanced-stage non-small cell lung cancer patients treated with intensity modulated radiation therapy[J].Int J Radiat Oncol Biol Phys,2017,99(2):434-441.12 李丹明,王黎,王沛沛,等.适形调强与容积旋转调强技术对局部晚期非小细胞肺癌临床效果比较[J].中国肿瘤,2016,25(9):742-746.13 Zhang J,Yu XL,Zheng GF,et al.Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment[J].Med Oncol,2015,32(4):94.14 宋明永,戴相昆,杜乐辉,等.3 种调强放疗方式治疗非小细胞肺癌的剂量学比较[J].中国医学物理学杂志,2017,34(2):121-124.15 刘建平,杨海芳,王志武,等.部分弧容积旋转调强计划在中央型肺癌的应用[J]。中国医学物理学杂志,2017,34(11):1091-1095.16 Danita K,Martina D,Aaron G,et al.Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors:a comparison of robotic radiosurgery,helical tomotherapy and volumetric modulated arc herapy[J].Technol Cancer Res Treat,2015,14(1):49-60.17 Zhao YQ,Chen L,Zhang S,et al.Predictive factors for acute radiation pneumonitis inpostoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer[J].Thorac Cancer,2015,6(1):49-57.18 Bongers EM,Botticella A,Palma DA,et al.Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs[J].Radiother Oncol,2013,109(1):95-99.19 Leprieur EG,Fernandez D,Chatellier G,et al.Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer:clinical,dosimetric,and associated-treatment risk factors[J].J Cancer Res Ther,2013,9(3):447-451.20 王天昶,冯杏,王浩,等.放疗前肺功能参数对非小细胞肺癌放射性肺炎的预测价值[J],实用癌症杂志,2016,31(4):581-584.21 Vogelius IR,Bentzen SM.A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumoniti[J].Acta Oncol,2012,51(8):975-983.22 吴双,杨泽,张远净,等.局部晚期非小细胞肺癌诱导化疗后同期放化疗与同期放化疗疗效及安全性Meta分析[J].中华肿瘤防治杂志,2017,24(1):55-61.23 Dang J,Li G,Zang S,et al.Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery[J].Lung Cancer,2014,86(3):329-333.

[1]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[2]	孙立春,李丹丹,李净,于凤玲. CCDC8和TGF-β1在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(3): 215-221.
[3]	刘志强,褚艳杰,刘静,王彦博. m白术内酯Ⅰ通过TLR4/MyD88通路调控肺癌A549细胞增殖侵袭的研究[J]. 实用肿瘤学杂志, 2019, 33(3): 228-232.
[4]	赵苏, 郑晓瑜, 朱开彬, 卜建龙, 徐世东. 肺癌完全性切除术对患者外周血中Th17/Treg细胞平衡的影响[J]. 实用肿瘤学杂志, 2019, 33(2): 142-148.
[5]	胡智慧综述, 张静审校. SNP对放射性肺损伤预测作用的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 87-91.
[6]	迪娜·木拉力, 胡昕综述, 加孜那·托哈依审校. 远程医疗在肺癌中的应用及前景[J]. 实用肿瘤学杂志, 2018, 32(6): 555-557.
[7]	李万祯, 殷俊, 李萍, 林晓辉, 张国前, 张书旭. iR-17在非小细胞肺癌放射抗拒细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(5): 391-397.
[8]	蔡静, 候玥. 非小细胞肺癌患者血清miR-195的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 415-419.
[9]	钟雪莱, 杨海粒, 王国年. 不同麻醉方式对老年肺癌患者术后认知功能的影响[J]. 实用肿瘤学杂志, 2018, 32(5): 432-436.
[10]	朱晓云, 张亚宁, 林菲, 马碧萍. 上海市金山区2002-2013年肺癌发病及死亡分析[J]. 实用肿瘤学杂志, 2018, 32(5): 437-441.
[11]	崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.
[12]	魏静, 陶媛美慧, 付英梅, 赵吉子, 张文莉, 张凤民. 肺结核与肺癌相互影响的研究进展[J]. 实用肿瘤学杂志, 2018, 32(4): 340-343.
[13]	雷俊华, 许冠华, 曾江正, 黄芬, 何志惠, 卢彦达. 隐丹参酮联合顺铂抗非小细胞肺癌NCI-H1975细胞JAK2/STAT3机制研究[J]. 实用肿瘤学杂志, 2018, 32(3): 198-202.
[14]	万静萱, 李红红, 周湘乡, 马琳. Ⅳ期肺癌合并肺血栓栓塞的危险因素分析[J]. 实用肿瘤学杂志, 2018, 32(3): 214-244.
[15]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.

CRT+ARC技术在局部晚期肺癌患者中临床应用的初步研究

The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 1

相关文章 15

编辑推荐

Metrics

本文评价